1. Home
  2. UPC vs CYCN Comparison

UPC vs CYCN Comparison

Compare UPC & CYCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UPC
  • CYCN
  • Stock Information
  • Founded
  • UPC N/A
  • CYCN N/A
  • Country
  • UPC China
  • CYCN United States
  • Employees
  • UPC N/A
  • CYCN N/A
  • Industry
  • UPC Biotechnology: Pharmaceutical Preparations
  • CYCN Biotechnology: Pharmaceutical Preparations
  • Sector
  • UPC Health Care
  • CYCN Health Care
  • Exchange
  • UPC Nasdaq
  • CYCN Nasdaq
  • Market Cap
  • UPC 8.7M
  • CYCN 7.8M
  • IPO Year
  • UPC 2021
  • CYCN N/A
  • Fundamental
  • Price
  • UPC $3.86
  • CYCN $3.39
  • Analyst Decision
  • UPC
  • CYCN
  • Analyst Count
  • UPC 0
  • CYCN 0
  • Target Price
  • UPC N/A
  • CYCN N/A
  • AVG Volume (30 Days)
  • UPC 103.5K
  • CYCN 10.4K
  • Earning Date
  • UPC 07-23-2024
  • CYCN 07-26-2024
  • Dividend Yield
  • UPC N/A
  • CYCN N/A
  • EPS Growth
  • UPC N/A
  • CYCN N/A
  • EPS
  • UPC N/A
  • CYCN N/A
  • Revenue
  • UPC $32,308,735.00
  • CYCN N/A
  • Revenue This Year
  • UPC N/A
  • CYCN N/A
  • Revenue Next Year
  • UPC N/A
  • CYCN N/A
  • P/E Ratio
  • UPC N/A
  • CYCN N/A
  • Revenue Growth
  • UPC N/A
  • CYCN N/A
  • 52 Week Low
  • UPC $0.75
  • CYCN $1.75
  • 52 Week High
  • UPC $4.32
  • CYCN $5.25
  • Technical
  • Relative Strength Index (RSI)
  • UPC 68.57
  • CYCN 54.18
  • Support Level
  • UPC $2.87
  • CYCN $2.92
  • Resistance Level
  • UPC $3.98
  • CYCN $3.94
  • Average True Range (ATR)
  • UPC 0.43
  • CYCN 0.39
  • MACD
  • UPC 0.07
  • CYCN 0.09
  • Stochastic Oscillator
  • UPC 77.62
  • CYCN 48.95

About UPC Universe Pharmaceuticals Inc.

Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.

About CYCN Cyclerion Therapeutics Inc.

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.

Share on Social Networks: